Trials / Unknown
UnknownNCT00793091
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract
A Phase 2, Randomized, Placebo-Controlled, Double-Masked, Multicenter Safety and Efficacy Study of C-KAD Ophthalmic Solution in Patients With Loss of Visual Acuity Due to Age-Related Cataract
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Chakshu Research, Inc. · Industry
- Sex
- All
- Age
- 50 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and efficacy of C-KAD Ophthalmic Solution in improving visual acuity relative to placebo in patients with age-related cataract
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | C-KAD Ophthalmic Solution | 4 drops applied daily for 120 days |
| DRUG | Placebo | 4 drops applied daily for 120 days |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2009-08-01
- Completion
- 2009-09-01
- First posted
- 2008-11-19
- Last updated
- 2008-11-27
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00793091. Inclusion in this directory is not an endorsement.